Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease - Wikidata - wikimedia - TriplyDB

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease

http://www.wikidata.org/entity/Q34794444

about

Quality of life in patients with Fabry disease: a systematic review of the literature.The Impact of Fabry Disease on Reproductive Fitness.Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.

P2860

Q35849151-B1CA98E7-54EA-4114-9EFE-FA07BFBC8025 Q38889928-BF350403-BD9C-42C6-98C3-BC5F63DB20CD Q47779398-1BD0FF2C-58D4-4034-8C9A-54D6AC8C0C80

P2860

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease

http://www.wikidata.org/entity/Q34794444

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Kidney function as an underest ...... in patients with Fabry disease

@ast

Kidney function as an underest ...... in patients with Fabry disease

@en

Kidney function as an underest ...... in patients with Fabry disease

@nl

type

label

Kidney function as an underest ...... in patients with Fabry disease

@ast

Kidney function as an underest ...... in patients with Fabry disease

@en

Kidney function as an underest ...... in patients with Fabry disease

@nl

prefLabel

Kidney function as an underest ...... in patients with Fabry disease

@ast

Kidney function as an underest ...... in patients with Fabry disease

@en

Kidney function as an underest ...... in patients with Fabry disease

@nl

P1433

Q34794444-7E9C0AF4-D798-4070-A7FC-734572ABCFD3

P1476

Q34794444-B649D963-27FF-400E-98BF-BC5261E2A95E

P2093

Q34794444-23FB9A08-03D3-4669-B40D-F5505E19A4EC

Q34794444-2E2C1EE3-F39E-48CF-9BE5-43A8F0A4BAC2

Q34794444-30C0601D-4382-49A6-912A-23C7883599CB

Q34794444-7C7B218C-7EE5-49A3-9B40-E16E8F8D61CC

Q34794444-9D59C233-2A25-4653-90D1-932E8A10E642

Q34794444-EDD248FF-56F0-4924-BE87-E2410E5F9284

P2860

Q34794444-03385394-A608-47CF-B03C-F57D08215A99

Q34794444-2D3CD9C7-A1D6-4F76-813A-F383EF6AF38D

Q34794444-45FA3716-5F40-48D6-AEFF-125BEB946458

Q34794444-62F6594C-638F-476E-A239-C59CF3708ED4

Q34794444-892BC1A1-9DD4-4B55-826F-6B7E5DF5B124

Q34794444-89AC0FC4-1B58-44C9-956E-84E3E6B128C4

Q34794444-8ADC3121-5033-40E5-A852-1E5DF44C9384

Q34794444-915A199A-2828-4C0E-BE80-F2BAF676A0A5

Q34794444-A010B4F1-10DF-4E60-8AAB-1C4E984CE91C

Q34794444-AD7B4149-BE42-4F02-AAC6-BD61EE25898A

P304

Q34794444-B76A10AA-BC88-4325-95C3-191AF9905EAC

P31

Q34794444-B6601B83-FF3F-452C-8B6A-EBCB03938177

P356

Q34794444-B7AE672C-5921-4A09-92B6-D5A62F806F72

P478

Q34794444-530C0504-DF2A-4586-BB12-0C2A6C338E1B

P50

Q34794444-F318FE54-6EBE-4D04-89F0-46D130F7B8A4

P577

Q34794444-ED29F132-268C-4A58-A08A-3F7639C44BFF

P5875

Q34794444-1B0BBE2D-2B81-442A-95C7-C84BC2D3D8D4

P698

Q34794444-0965A818-DA4B-467E-A9AB-C85BED84CED8

P921

Q34794444-BC335C34-9DDD-498B-B575-A62821A9A6CA

P932

Q34794444-A7DE8BA1-1C3A-4F82-9D6F-C8407F8CDE56

P356

1471-2369-15-188

P1433

P1476

Kidney function as an underest ...... in patients with Fabry disease

@en

P2093

Christoph Wanner

http://www.w3.org/2001/XMLSchema#string

Dorothee Vergho

http://www.w3.org/2001/XMLSchema#string

Elisabeth Blohm

http://www.w3.org/2001/XMLSchema#string

Frank Breunig

http://www.w3.org/2001/XMLSchema#string

Frank Weidemann

http://www.w3.org/2001/XMLSchema#string

Martin Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry

Temporal trends in health-related quality of life among hemodialysis patients in the United States.

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

Natural history of Fabry disease in females in the Fabry Outcome Survey.

Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.

P304

188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2369-15-188

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Krämer

P577

2014-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268986227

http://www.w3.org/2001/XMLSchema#string

P698

25432518

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

4280765

http://www.w3.org/2001/XMLSchema#string